ALB and hepatocellular carcinoma: The study comprehensively analyzed and identified mutated genes in HCC through multi-omics testing of a large number of HCC clinical samples, and identified abnormal genes albumin (ALB), apolipoprotein B (APOB), carbamoyl phosphate synthetase 1 (CPS1) that lead to metabolic reprogramming in HCC.